E-mail

E-mail a Wiley Online Library Link

Anna Grenabo Bergdahl, Gunnar Aus, Hans Lilja and Jonas Hugosson Risk of dying from prostate cancer in men randomized to screening Cancer 115

Version of Record online: 7 OCT 2009 | DOI: 10.1002/cncr.24680

Although the true benefits and disadvantages of prostate cancer screening are still not known, the analysis of fatal cases is important for contributing to the knowledge of the effects of prostate cancer screening on mortality. The Swedish branch of the European Randomized Study of Screening for Prostate Cancer found that nonattendees in prostate cancer screening constitute a high-risk group for death from both prostate cancer and other unrelated causes.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH